Most Recent Additions*

PDF

Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.
Salma K Jabbour, Ki Hyeong Lee, Nikolaj Frost, Valeriy Breder, Dariusz M Kowalski, Theodore Pollock, Evgeny Levchenko, Noemi Reguart, Alex Martinez-Marti, Baerin Houghton, Jean-Baptiste Paoli, Sufia Safina, Keunchil Park, Takefumi Komiya MD, Amy Sanford, Vishal Boolell, Hong Liu, Ayman Samkari, Steven M Keller, and Martin Reck

Link

KEYNOTE-799: Phase 2 trial of pembrolizumab plus platinum chemotherapy and radiotherapy for unresectable, locally advanced, stage 3 NSCLC.
Salma K. Jabbour, Ki Hyeong Lee, Nicolaj Frost, Valeriy Vladimirovich Breder, Dariusz M. Kowalski, Issam Abdelkarim Alawin, Evgeny Levchenko, Noemi Reguart, Alex Martinez-Marti, Baerin Houghton, Jean-Baptiste Paoli, Sufia Safina, Keunchil Park, Takefumi Komiya MD, Amy Sanford, Vishal Boolell, Hong Liu, Ayman Samkari, Steven M. Keller, and Martin Reck

PDF

Perceptions and behaviors of learner engagement with virtual educational platforms.
K J Dickinson; K E Caldwell; E A Graviss; D T Nguyen; M M Awad; J Olasky; S Tan; J H Winer; and Kevin Y. Pei MD, MHSEd, FACS

PDF

Pharmacist Impact on Cardiology Bundle Payments for Care Improvement and Patient Outcomes
Megan Wagner PharmD; Jordan Holder PharmD; and Priya Verma PharmD, BCACP

PDF

Evaluation of Emergency Department Treatment of Pediatric Asthma Exacerbations
Paige Walker PharmD; Amber Ooley PharmD, BCPS, BCCCP; and Kassandra Foellinger PharmD, BCPS

PDF

Evaluation of Calcitonin Use for Hypercalcemia at Parkview Health
Alison Rydell; Jesse Christman PharmD, BCOP; and Jamie Gaul PharmD, BCPS

PDF

Characterization of Infliximab and Biosimilar Use in a Community Health System
Abigail Geyer PharmD; Luke Keller PharmD, BCPS, BCCCP; Curtis Stump PharmD; and Renu Johnson PharmD, BCPS

PDF

Assessing Consistency with Standards of Care Recommendations for Patients with Type 2 Diabetes at Hospital Discharge
Katherine Brown PharmD; Timothy L. Johnston BPharm, PharmD, BCPS, BCCCP; and Andrea Sloat PharmD

PDF

Implementation and Outcomes Assessment of a 4-factor prothrombin complex concentrate (4F-PCC) Tiered Fixed Dosing Protocol in a Health System.
Mark Botros BS; Jamie Gaul PharmD, BCPS; Dana Lorber PharmD, BCPS; and Sarah Koontz PharmD, BCPS

PDF

Evaluation of Benefits Associated with Chemotherapy Dose-Banding Practices
Alexis Mann PharmD, MBA; Kyle Becker PharmD, MBA, BCOP; and Jesse Christman PharmD, BCOP

PDF

Comparison of Standard Dose vs Higher Dose Low Molecular Weight Heparin and Unfractionated Heparin for DVT Prophylaxis in COVID-19 Patients
Zachary Brown PharmD; Munyaradzi Chakabva MD; Tabinda Akhtar MD; Sarah Polina PharmD, BCPS; Michael Todt PharmD, BCCCP; Mckenna Brauner NP; Meghan McGuire NP; and Aws Polina MD

PDF

Standardized approach to implementation of infusion pump interoperability
Tara Jellison PharmD, MBA, FASHP and Rebecca S. Mahuren BSN, RN

PDF

A retrospective evaluation of non-operative use of push dose phenylephrine in critically ill adults
Erin Dark; Dustin D Linn PharmD, BCPS, BCCCPS; Jamie Gaul PharmD, BCPS; and Abby L. Todt PharmD, BCPS

PDF

An Evaluation of Vancomycin Use in Patients with Urosepsis
Curtis Stump PharmD; Shahinda Mohmed; and Dustin D Linn PharmD, RPh, BCCCP

*Updated as of 05/17/22.